The future looks promising as research continues and new options become available
doi: 10.1021/jf502022w 82 UngY
The weight loss produced by GLP-1 medications is genuine and clinically significant trials of semaglutide (Wegovy) have shown average weight loss of 15 to 20% of body weight over 68 weeks, which is comparable to the outcomes of bariatric surgery for many patients
Yes, semaglutide can indirectly enhance your sex life by promoting substantial weight loss, which may boost self-esteem, improve body image, and support better sexual function and hormonal health
In addition, if you suffer from kidney problems, heart failure or diabetic ketoacidosis it is important to tell your doctor before starting on either of these medications
[33] report that rats fasted for 48 hours lose approximately 44% of the intracellular GSH in their hepatocytes